Rapid technological advances in the field of molecular generics are be
ing applied successfully to the analysis of migraine. Specific mutatio
ns leading to an increased risk of rare forms of migraine have been id
entified in both mitochondrial DNA and a calcium channel gene. Associa
tion studies have demonstrated that polymorphic variations in serotone
rgic and dopaminergic genes may alter the clinical susceptibility to m
igraine. Massive amounts of additional genetic data relating to migrai
ne will be generated in the next few years. These data are revolutioni
zing the diagnosis and management of migraine, a heretofore subjective
clinical disorder. (C) 1998 Wiley-Liss, Inc.